David P. Hochman
2023
In 2023, David P. Hochman earned a total compensation of $6.9M as Chief Executive Officer & Chairman at Orchestra BioMed Holdings, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $347,000 |
|---|---|
| Option Awards | $2,507,368 |
| Salary | $595,000 |
| Stock Awards | $3,450,300 |
| Total | $6,899,668 |
Hochman received $3.5M in stock awards, accounting for 50% of the total pay in 2023.
Hochman also received $347K in non-equity incentive plan, $2.5M in option awards and $595K in salary.
Rankings
In 2023, David P. Hochman's compensation ranked 52nd out of 2,978 executives tracked by ExecPay. In other words, Hochman earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 52 out of 2,978 | 98th |
Division Manufacturing | 25 out of 1,637 | 99th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 3 out of 256 | 99th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 2 out of 188 | 99th |
Industry Surgical and Medical Instruments and Apparatus | 2 out of 144 | 99th |
Source: SEC filing on April 30, 2024.
Hochman's colleagues
We found two more compensation records of executives who worked with David P. Hochman at Orchestra BioMed Holdings in 2023.